Experimental oncology

The experimental oncology group is engaged in research in the following areas:
- new controlled materials for drug delivery to tumors
- molecular mechanisms of the death of tumor cells upon p53 and Mdm2 separation
- targeted inhibition of Clk protein kinase to trigger the death of tumor cells
- necroptosis in antitumor therapy